A Clinical Study of iNSC Intervent Cerebral Hemorrhagic Stroke

Clinical trial NCT03725865 · UNKNOWN

Trial details

NCT number: NCT03725865
Sponsor: Allife Medical Science and Technology Co., Ltd.
Status: UNKNOWN
Phase: Early Phase 1
Study type: INTERVENTIONAL

Stroke, Ischemic

Start date: 2019-03-01
Primary completion: 2019-03-01
Enrollment: 12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.